Our columnists crack open the murky world of finance and investments
Author of 'No Spend Year' answers the four pension questions she is most often asked by friends and family.
James Carthew examines the trusts investing in the smallest of small companies, including River and Mercantile's soaraway fund.
Alastair Mundy's Temple Bar has shot back to form, making its shares look relatively dear compared to other equity income trusts.
A goal of income growth has held back performance of Polar Capital Global Healthcare Trust. Its successor may take a new approach.
James Carthew assesses RM Secured Direct Lending, the latest closed-end income fund to focus on loans to credit-starved businesses.
The shopping is going to cost us all more this year, and here's why, says author of 'No Spend Year'.
Matthew Read picks out three investment trusts which could offer some protection, or even benefit, should markets fall.
Syncona, the former Battle Against Cancer Investment Trust, falls to a discount as investors adjust to decision to fight disease more directly.
If you put the effort into saving some money, your employer and the government will reward you, says author of ’No Spend Year’.
With many investment trusts on all-time highs we look at what bargain hunters at Hawskmoor Investment Management have been bagging.
How will our novice fare on the markets?
Dumb Investor: 'If I do lose it all in some kind of Madoff-style scam... at least my humiliation will be public.'
Dumb Investor's latest articles
Investment Trust Insider
James Carthew shares his expert knowledge to give you the inside track on investment trusts.